Genetic background of cutaneous forms of lupus erythematosus: Update on current evidence

Journal of Applied Genetics

Volumn 45, Issue 1, 2004, Pages 77-86

  Osmola, Agnieszka ^a   Namysł, Jakub ^a   Jagodziński, Paweł P ^a   Prokop, Janusz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Cutaneous lupus erythematosus; Gene; Human endogenous retroviruses; Major histocompatibility complex

Indexed keywords

CELL ADHESION MOLECULE; CELL PROTEIN; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS ANTIGEN; FC RECEPTOR; HEAT SHOCK PROTEIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; RECEPTOR SUBTYPE; T LYMPHOCYTE RECEPTOR BETA CHAIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; AUTOIMMUNITY; CELL FUNCTION; DISEASE EXACERBATION; DNA POLYMORPHISM; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROVIRUS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SKIN LUPUS ERYTHEMATOSUS;

APOPTOSIS; CELL ADHESION MOLECULES; CYTOKINES; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MAJOR HISTOCOMPATIBILITY COMPLEX; RETROVIRIDAE;

HUMAN ENDOGENOUS RETROVIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 1642294034     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. BANKI K., MACEDA J., HURLEY E., ABLONCZY E., MATTSON D.H, SZEGEDY L. (1992). Human T-cell lymphotropic virus HTLV-related endogenous sequence HRES-1, encodes a 28 kDa protein: a possible autoantigen for HTLV-1 gag reactive autoantibodies. Proc. Nat. Acad. Sci. USA 31: 735-742.
2. BIELSA I., HERRERO C., ERCILLA G., COLLADO A., FONT J., INGELMO M., MASCARO J.M. (1991). Immunopathogenic findings in cutaneous lupus erythematosus. J. Am. Acad. Dermatol. 25: 251-257.
3. BLAKEMORE A.I., TARLOW J.K., CORK M.J., GORDON C., EMERY P., DUFF G.W. (1994). Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus. Arthritis Rheum. 37: 1380-1385.
4. BURCH R.P., ROWELL N.R. (1968). The sex and age distributions of chronic discoid lupus erythematosus in four countries. Possible aetiopathological and pathogenic significance. Acta Derm. Venerol. 48: 33-46.
5. CALLEN J.P. (2002). Lupus erythematosus, Discoid. Available: http://www.emedicine. com/derm/topic247.htm, October 2002.
6. CALLEN J.P. (2002). Lupus erythematosus, Subacute cutaneous. Available: http://www.emedicine.com/derm/topic248.htm, October 2002.
7. CHARMAINE B. (2002). Lupus erythematosus, Acute. Available: http://www.emedicine. com/derm/topic245.htm, October 2002.
8. FISCHER G.F., PICK W.F., FAE I., ANEGG B., MILOTA S., VOLC-PLATZER B. (1994). Association between chronic cutaneous lupus erythematosus and HLA class II alleles. Hum. Immunol. 41: 280-284.
9. FRANK M.B., MCARTHUR R., HARLEY J.B., FUJISAKU A. (1990). Anti-Ro (SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients. J. Clin. Invest. 85: 33-39.
10. GHOREISHI M., KATAYAMA I., YOKOZEKI H., NISHIOKA K. (1993). Analysis of 70 KD heat shock protein expression in the lesional skin of lupus erythematosus and related diseases. J. Dermatol. 101: 191-195.
11. GRZYBOWSKI J., SCHWARTZ A.R. (2002). Neonatal Lupus Erythematosus. Available: http://www.emedicine.com/derm/topic246.htm, October 2002.
12. INTERNATIONAL HUMAN GENOME SEQUENCING CONSORTIUM. (2001). Initial sequencing and analysis of the human genome. Nature 409: 860-921.
13. LAWRENCE J.S., MARTINS C.L., DRAKE G.L. (1987). A family survey of lupus erythematosus. Heritability J. Rheumatol. 14: 913-912.
14. LAZARUS M., HAJEER A.H., TURNER D., SINNOTT P., WORTHINGTON J., OLLIER W.E., HUTCUINSON I.V. (1997). Genetic variation in the interleukin 10 gene promoter variation and systemic lupus erythematosus. J. Rheumatol. 24: 2314-2317.
15. LI J., FAN W.S., HORSFALL A.C., ANDERSON A.C., RIGBY S., LARSSON E., VENABLES P.J. (1996). The expression of HERV-3 in fetal cardiac tissue and antibodies in CHB. Clin. Exp. Immunol. 104: 388-393.
16. LIPSKER D.M., SCHRECKENBERG-GILLIOT C., URING-LAMBERT B., MEYER A., HARTMANN D., GROSSHANS E.M., HAUPTMANN G. (2000). Lupus erythematosus associated with genetically determined deficiency of the second component of the complement. Arch. Dermatol. 136: 1508-1514.
17. MILLARD L.G., ROWELL N.R., RAJAH S.M. (1977). Histocompatibility antigens in discoid and systemic lupus erythematosus. Br. J. Dermatol. 96: 139-144.
18. MILLARD T.P., MCGREGOR J.M. (2001). Molecular genetics of cutaneous lupus erythematosus. Clin. Exp. Dermatol. 26: 184-191.
19. MILLARD T.P., KONDEATIS E., VAUGHAN R.W., LEWIS C.M., KHAMASTHA M.A., HUGHES G.R.V., HAWK J.L.M., MCGREGOR J.M. (2001). Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 10: 473-479.
20. MILLARD T.P., ASHTON G.H.S., KONDEATIS E., VAUGHAN R.W., HUGHES G.R.V., KHAMASHTA M.A., HAWK J.L.M., MCGREGOR J.M., MCGRATH J.A. (2002). Human Ro (SSA2) genomic organization and sequence alterations, examined in cutaneous lupus erythematosus. Br. J. Dermatol. 146: 210-215.
21. MILLARD T.P., KONDEATIS E., COX A., WILSON A.G., GRABCZYNSKA S.A., CAREY B.S., LEWIS C.M., KHAMASHTA M.A., DUFF G.W., HUGHES G.R.V., HAWK J.L.M., VAUGHAN R.W., MCGREGOR J.M. (2001). A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br. J. Dermatol. 145: 229-236.
22. NAKAJIMA M., NAKAJIMA A., KAYAGAKI N., MONDO M. YAGITA H., OKUMURA K. (1997). Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury. Clin. Immunol. Irnmunopathol. 83: 223-229.
23. NORRIS D. A. (1993). Pathomechanisms of photosensitive lupus erythematosus. J. Invest. Dermatol. 100: 58-68.
24. NOUSARI H.C., KIMYAI-ASADI A., PROVST T.T. (1999). Generalized lupus erythematosus profundus in a patient with genetic partial deficiency of C4. J. Am. Dermatol. 41: 362-364.
25. NYBERG F., HASAN T., SKOGLUND C., STEPHANSON E. (1999). Early events in ultraviolet light-inducted skin lesions in lupus erythematosus: expression patterns of adhesion molecules ICAM-1, VCAM-1 and E-selectin. Acta Derm. Venerol. 79: 431-436.
26. OLLIER W., DAVIES E., SNOWDEN N., AUDERSEA J., FRYER A., JONES P., STRANGE R. (1996). Association of homozygosity for glutathione-S-transferase GSTM1 null alleles with the Ro+/La-autoantibody profile in patients with systemic lupus erythematosus. Arthritis Rheum. 39: 1763-1764.
27. PATEL P., WERTH V. (2002). Cutaneous lupus erythematosus: a review. Dermatol. Clin. 20: 373-385.
28. PEARL A. (2001). Endogenous retroviruses in pathogenesis of autoimmunity. J. Rheumatol. 28: 3.
29. PEARL A., ISAACKS C.M., EDDY R.L., BYERS M.G., SAINT S.N., SHOWS T.B. (1991). The Human T-cell leukemia virus related endogenous sequence HRES-1 is located on chromosome 1 at q42. Genomics 11: 1172-1173.
30. PORTIS J. (2002). Perspectives on the role of endogenous human retroviruses in autoimmune diseases. Virology 296: 1-5.
31. PROKOP J., KURPISZ M. (1996). The role of retroviral sequences in anti-DNA antibody development in systemic lupus erythematosus. Cent.-Eur. J. Immunol. 21: 246-250.
32. PROKOP J., KURPISZ M. (1998). Retroviral agents in DNA from sera of patients with cutaneous forms of lupus erythematosus. Cent.-Eur. J. Immunol. 23: 221-226.
33. RIDGWAY W.M., FASSO M., FATHMAN G.C. (1999). A new look at MHC and autoimmune diseases. Science 284: 749-751.
34. SEQUIRA J.H. (1903). Lupus erythematosus in two sisters. Br. J. Dermatol. 15: 171.
35. STEAGALL R.W., ASH H.T., FENTANES L.B. (1962). Familial lupus erythematosus. Arch. Dermatol. 85: 394-396.
36. STONE N.M., WILLIAMS A., WILKINSON J.D., BIRD G. (2000). Systemic lupus erythematosus with C1q deficiency. Br. J. Dermatol. 142: 521-524.
37. TEBBE B., MANSMANN U., WOLLINA U., AUER-GRUMBACH P., LICHT-MBALYOHERE A., ARENSMEINER M., ORFANOS C.E. (1997). Markers in Cutaneous lupus erythematosus indicating systemic involvement. Acta Derm. Venerol. 77: 305-308.
38. THE MHC SEQUENCING CONSORTIUM. (1999). Complete sequence and gene map of a human MHC. Nature 40: 921-923.
39. URNOVITZ H.B., MURPHY W.H. (1996). Human endogenous retroviruses: nature, occurrence and clinical implications in human disease. Clinical Microbiology Reviews 72-99.
40. WATANABE-FUKUNAGA R., BRANNAN C.L., COPELAND N.G., JENKINS N.A., NAGATA S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediated apoptosis. Nature 356: 314-317.
41. WERTH V. (2002). Current treatment of cutaneous lupus erythematosus. Dermatol. Online J. 7(1): 2, Available: http://www.dermatology.cdlib.org/ DOJvo17num1/ transactions/lupus/werth.html, October 2002.
42. WERTH V.P., ZHANG W., DORTZBACH K., SULLIVAN K. (2000). Association of a promoter polymorphism of tumor necrosis factor-alpha with SCLE and distinct photoregulation of transcription. J. Invest. Dermatol. 115(4): 726-730.
43. ZHU Z.B., HSIEH S., BENTLEY D.R., CAMPBEL D., VOLANKIS J.E. (1992). A variable number of tandem repeat locus within the human complement C2 gene is associated with a retropozon derived form of HERV. J. Exp. Med. 175: 1783-1787.